(Q44786991)

6 December 2017

title

Experience with clonidine-naltrexone for rapid opiate detoxification (English)

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

23 November 2022

0 references

R. A. Senft

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1787550

23 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1787550

23 November 2022

publication date

1 January 1991

1 reference

full work available at URL

6 December 2017

https://api.elsevier.com/content/article/PII:074054729190048F?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

https://api.elsevier.com/content/article/PII:074054729190048F?httpAccept=text/plain

23 November 2022

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

Journal of Substance Abuse Treatment

23 November 2022

published in

1 reference

6 December 2017

volume

8

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

257-259

1 reference

Naloxone for Diagnosis in Methadone Programs

6 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique

23 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone

23 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy.

23 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms

23 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

Clonidine in opiate withdrawal

23 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

Clonidine blocks acute opiate-withdrawal symptoms

23 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

Clonidine in outpatient detoxification from methadone maintenance

23 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

Clonidine and naltrexone in the outpatient treatment of heroin withdrawal.

23 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

Rapid detoxification of the narcotic addict with naloxone hydrochloride. A preliminary report

23 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study

23 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

Clinical Utility of Rapid Clonidine-naltrcxone Detoxification for Opioid Abusers

23 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

Clonidine for opiate detoxification: outpatient clinical trials

23 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0740-5472(91)90048-F

23 November 2022

Identifiers

1 reference

6 December 2017

1 reference